{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:49:40Z","timestamp":1792093780515,"version":"4.4.0"},"reference-count":186,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["K2023005"],"award-info":[{"award-number":["K2023005"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.critrevonc.2025.104773","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T12:00:27Z","timestamp":1747915227000},"page":"104773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Radiosensitization strategies for hepatocellular carcinoma: Mechanisms, therapeutic advances, and clinical perspectives"],"prefix":"10.1016","volume":"213","author":[{"given":"Jiahui","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0723-5235","authenticated-orcid":false,"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2025.104773_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1748-717X-8-239","article-title":"A phase I study on combined therapy with proton-beam radiotherapy and in situ tumor vaccination for locally advanced recurrent hepatocellular carcinoma","volume":"8","author":"Abei","year":"2013","journal-title":"Radiat. Oncol."},{"issue":"1_ement","key":"10.1016\/j.critrevonc.2025.104773_bib2","article-title":"Abstract A094: Phase I modular study of AZD0156, a first-in-class oral selective inhibitor of ataxia telangiectasia mutated protein kinase (ATM), in combination with olaparib (AToM Study, Module 1)","volume":"17","author":"Abida","year":"2018","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104773_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098308","article-title":"Synergistic Nanomedicine: Photodynamic, Photothermal and Photoimmune Therapy in Hepatocellular Carcinoma: Fulfilling the Myth of Prometheus?","volume":"24","author":"Ailioaie","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104773_bib4","article-title":"Oxidative Stress in Liver Pathophysiology and Disease","volume":"12","author":"Allameh","year":"2023","journal-title":"Antioxid. (Basel)"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3892\/ijo.2012.1583","article-title":"The mTOR inhibitor RAD001 augments radiation-induced growth inhibition in a hepatocellular carcinoma cell line by increasing autophagy","volume":"41","author":"Altmeyer","year":"2012","journal-title":"Int J. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104773_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.critrevonc.2025.104773_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7608712","article-title":"Dysregulation of EZH2\/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1\u03b1)","volume":"2022","author":"Bai","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030746","article-title":"Elevated PDK1 Expression Drives PI3K\/AKT\/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma","volume":"9","author":"Bamodu","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33233-0","article-title":"Early heme oxygenase 1 induction delays tumour initiation and enhances DNA damage repair in liver macrophages of Mdr2(-\/-) mice","volume":"8","author":"Barikbin","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000537","article-title":"Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma","volume":"8","author":"Barsoumian","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104773_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcancer.2023.11.006","article-title":"Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities","volume":"98","author":"Beckers","year":"2024","journal-title":"Semin Cancer Biol."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104773_bib12","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/1759-7714.14923","article-title":"Genomic profile of Pancoast syndrome due to hepatocellular carcinoma: A case report","volume":"14","author":"Bergman","year":"2023","journal-title":"Thorac. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104773_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib14","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2025.104773_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216507","article-title":"Olaparib enhances radiation-induced systemic anti-tumor effects via activating STING-chemokine signaling in hepatocellular carcinoma","volume":"582","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104773_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fonc.2020.00004","article-title":"Hypofractionated Irradiation Suppressed the Off-Target Mouse Hepatocarcinoma Growth by Inhibiting Myeloid-Derived Suppressor Cell-Mediated Immune Suppression","volume":"10","author":"Chen","year":"2020","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells12020332","article-title":"Effect of Proton Therapy on Tumor Cell Killing and Immune Microenvironment for Hepatocellular Carcinoma","volume":"12","author":"Chen","year":"2023","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104773_bib18","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/mc.23421","article-title":"Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma","volume":"61","author":"Chen","year":"2022","journal-title":"Mol. Carcinog."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104773_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065257","article-title":"Cathepsin H Knockdown Reverses Radioresistance of Hepatocellular Carcinoma via Metabolic Switch Followed by Apoptosis","volume":"24","author":"Chen","year":"2023","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104773_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.abb.2018.03.018","article-title":"Long non-coding RNA ROR promotes radioresistance in hepatocelluar carcinoma cells by acting as a ceRNA for microRNA-145 to regulate RAD18 expression","volume":"645","author":"Chen","year":"2018","journal-title":"Arch. Biochem Biophys."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib21","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ijrobp.2011.01.003","article-title":"Sonic hedgehog signaling protects human hepatocellular carcinoma cells against ionizing radiation in an autocrine manner","volume":"80","author":"Chen","year":"2011","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104773_bib22","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.3748\/wjg.v29.i24.3871","article-title":"Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial","volume":"29","author":"Chen","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/15384047.2016.1156258","article-title":"Ganetespib radiosensitization for liver cancer therapy","volume":"17","author":"Chettiar","year":"2016","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib25","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S2468-1253(22)00339-9","article-title":"Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial","volume":"8","author":"Chiang","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030554","article-title":"Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells","volume":"10","author":"Choi","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104773_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092573","article-title":"Radiation-Induced Metabolic Shifts in the Hepatic Parenchyma: Findings from (18)F-FDG PET Imaging and Tissue NMR Metabolomics in a Mouse Model for Hepatocellular Carcinoma","volume":"26","author":"Chung","year":"2021","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.21037\/jgo.2019.04.02","article-title":"Proton beam therapy for liver cancers","volume":"11","author":"Chuong","year":"2020","journal-title":"J. Gastrointest. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.ijrobp.2016.01.028","article-title":"Wee1 Kinase Inhibitor AZD1775 Radiosensitizes Hepatocellular Carcinoma Regardless of TP53 Mutational Status Through Induction of Replication Stress","volume":"95","author":"Cuneo","year":"2016","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"29","key":"10.1016\/j.critrevonc.2025.104773_bib30","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.19.00730","article-title":"Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer","volume":"37","author":"Cuneo","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104773_bib31","article-title":"Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology\/RTOG 1112 Phase 3 Randomized Clinical Trial","author":"Dawson","year":"2024","journal-title":"JAMA Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175369","article-title":"Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation","volume":"134","author":"Dillon","year":"2024","journal-title":"J. Clin. Invest"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104773_bib33","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.7150\/thno.45017","article-title":"Tumor microenvironment-responsive multifunctional peptide coated ultrasmall gold nanoparticles and their application in cancer radiotherapy","volume":"10","author":"Ding","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2025.104773_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/15347354221151021","article-title":"Pomegranate Peel Extract Sensitizes Hepatocellular Carcinoma Cells to Ionizing Radiation, Induces Apoptosis and Inhibits MAPK, JAK\/STAT3, \u03b2-Catenin\/NOTCH, and SOCS3 Signaling","volume":"22","author":"Elbakry","year":"2023","journal-title":"Integr. Cancer Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104773_bib35","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/hep.32177","article-title":"Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC","volume":"75","author":"Fang","year":"2022","journal-title":"Hepatology"},{"issue":"Pt 1","key":"10.1016\/j.critrevonc.2025.104773_bib36","article-title":"Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammation","volume":"278","author":"Fu","year":"2024","journal-title":"Int J. Biol. Macromol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104773_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27345","article-title":"Compound Taxus exerts marked anti-tumor activity and radiosensitization effect on hepatocellular carcinoma cells","volume":"10","author":"Gao","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12951-022-01316-w","article-title":"Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma","volume":"20","author":"Gao","year":"2022","journal-title":"J. Nanobiotechnology"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104773_bib39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41388-023-02935-9","article-title":"TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma","volume":"43","author":"Geng","year":"2024","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104773_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.09.014","article-title":"PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles' heel?","volume":"45","author":"Gerossier","year":"2021","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104773_bib41","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","article-title":"Targeting ROS in cancer: rationale and strategies","volume":"23","author":"Glorieux","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.critrevonc.2025.104773_bib42","article-title":"A self-gelling hemostatic powder boosting radiotherapy-elicited NK cell immunity to combat postoperative hepatocellular carcinoma relapse","volume":"317","author":"Gong","year":"2024","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104773_bib43","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1177\/09603271211027948","article-title":"Inhibiting p21-activated kinase (PAK7) enhances radiosensitivity in hepatocellular carcinoma","volume":"40","author":"Gu","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.critrevonc.2025.104773_bib44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/1471-2407-14-603","article-title":"PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models","volume":"14","author":"Guillot","year":"2014","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.clinre.2013.07.006","article-title":"Update on hepatocellular carcinoma breakthroughs: poly(ADP-ribose) polymerase inhibitors as a promising therapeutic strategy","volume":"38","author":"Guillot","year":"2014","journal-title":"Clin. Res Hepatol. Gastroenterol."},{"key":"10.1016\/j.critrevonc.2025.104773_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.115767","article-title":"Multifaceted role of NF-\u03baB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches","volume":"228","author":"Gupta","year":"2023","journal-title":"Environ. Res"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104773_bib47","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med"},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104773_bib48","article-title":"RECQL4 Inhibits Radiation-Induced Tumor Immune Awakening via Suppressing the cGAS-STING Pathway in Hepatocellular Carcinoma","volume":"11","author":"Hong","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib49","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12935-023-03168-2","article-title":"Circular RNA circEYA3 promotes the radiation resistance of hepatocellular carcinoma via the IGF2BP2\/DTX3L axis","volume":"23","author":"Hu","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.critrevonc.2025.104773_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2018.07.010","article-title":"Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response","volume":"102","author":"Huang","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.118.249102","article-title":"Antagonizing SET Augments the Effects of Radiation Therapy in Hepatocellular Carcinoma through Reactivation of PP2A-Mediated Akt Downregulation","volume":"366","author":"Huang","year":"2018","journal-title":"J. Pharm. Exp. Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2014.04.006","article-title":"A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3","volume":"349","author":"Huang","year":"2014","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib53","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00210-022-02347-8","article-title":"Osthole increases the radiosensitivity of hepatoma cells by inhibiting GSK-3\u03b2\/AMPK\/mTOR pathway-controlled glycolysis","volume":"396","author":"Huang","year":"2023","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","article-title":"DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","article-title":"DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer","volume":"5","author":"Huang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2025.104773_bib56","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2021.06.034","article-title":"Wnt\/\u03b2-catenin inhibitor ICG-001 enhances the antitumor efficacy of radiotherapy by increasing radiation-induced DNA damage and improving tumor immune microenvironment in hepatocellular carcinoma","volume":"162","author":"Huang","year":"2021","journal-title":"Radio. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib57","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1038\/s41598-017-03407-3","article-title":"The miR-125a\/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma","volume":"7","author":"Jin","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijrobp.2022.09.052","article-title":"Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced\/Unresectable Hepatocellular Carcinoma","volume":"115","author":"Juloori","year":"2023","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"Pt 3","key":"10.1016\/j.critrevonc.2025.104773_bib59","article-title":"Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application","volume":"242","author":"Karimi","year":"2023","journal-title":"Int J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijrobp.2020.01.027","article-title":"Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib for Advanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial","volume":"107","author":"Kim","year":"2020","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib61","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1269\/jrr.11110","article-title":"Combination of radiotherapy and adenovirus-mediated p53 gene therapy for MDM2-overexpressing hepatocellular carcinoma","volume":"53","author":"Koom","year":"2012","journal-title":"J. Radiat. Res"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104773_bib62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrc3038","article-title":"Otto Warburg's contributions to current concepts of cancer metabolism","volume":"11","author":"Koppenol","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104773_bib63","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/mc.23769","article-title":"The cumulative antitumor effects of regorafenib and radiotherapy in hepatocellular carcinoma","volume":"63","author":"Kuang","year":"2024","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib64","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ijrobp.2016.08.007","article-title":"Targeting Phosphatidylinositol 4-Kinase III\u03b1 for Radiosensitization: A Potential Model of Drug Repositioning Using an Anti-Hepatitis C Viral Agent","volume":"96","author":"Kwon","year":"2016","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2025.104773_bib65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lfs.2015.06.006","article-title":"Paclitaxel pretreatment overcomes hypoxia inducible factor-1\u03b1-induced radioresistance acquisition of human hepatoma and lung adenocarcinoma cells","volume":"136","author":"Lai","year":"2015","journal-title":"Life Sci."},{"issue":"7777","key":"10.1016\/j.critrevonc.2025.104773_bib66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/d41586-019-02963-0","article-title":"Biologists who decoded how cells sense oxygen win medicine Nobel","volume":"574","author":"Ledford","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2025.104773_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106753","article-title":"Efficacy and feasibility of surgery and external radiotherapy for hepatocellular carcinoma with portal invasion: A meta-analysis","volume":"104","author":"Lee","year":"2022","journal-title":"Int J. Surg."},{"key":"10.1016\/j.critrevonc.2025.104773_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.568759","article-title":"Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond","volume":"11","author":"Lee","year":"2020","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104773_bib69","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","article-title":"Ferroptosis, radiotherapy, and combination therapeutic strategies","volume":"12","author":"Lei","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.critrevonc.2025.104773_bib70","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2147\/JHC.S432542","article-title":"Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre","volume":"10","author":"Li","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib71","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2119055","article-title":"Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling","volume":"14","author":"Li","year":"2022","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib72","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s13046-019-1419-1","article-title":"Apatinib potentiates irradiation effect via suppressing PI3K\/AKT signaling pathway in hepatocellular carcinoma","volume":"38","author":"Liao","year":"2019","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"Pt 2","key":"10.1016\/j.critrevonc.2025.104773_bib73","article-title":"CircNOP14 increases the radiosensitivity of hepatocellular carcinoma via inhibition of Ku70-dependent DNA damage repair","volume":"264","author":"Lin","year":"2024","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.critrevonc.2025.104773_bib74","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lfs.2018.02.015","article-title":"\u03b3-Glutamylcysteine synthetase (\u03b3-GCS) as a target for overcoming chemo- and radio-resistance of human hepatocellular carcinoma cells","volume":"198","author":"Lin","year":"2018","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib75","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.gendis.2019.12.008","article-title":"Study on the hepatocellular carcinoma model with metastasis","volume":"7","author":"Lin","year":"2020","journal-title":"Genes Dis."},{"key":"10.1016\/j.critrevonc.2025.104773_bib76","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejphar.2018.10.031","article-title":"A phenanthroline derivative enhances radiosensitivity of hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis","volume":"843","author":"Liu","year":"2019","journal-title":"Eur. J. Pharm."},{"issue":"35","key":"10.1016\/j.critrevonc.2025.104773_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202400954","article-title":"Enhancing X-Ray Sensitization with Multifunctional Nanoparticles","volume":"20","author":"Liu","year":"2024","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104773_bib78","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/abbs\/gmx096","article-title":"Effects of 12C6+\u2009heavy ion beam irradiation on the p53 signaling pathway in HepG2 liver cancer cells","volume":"49","author":"Liu","year":"2017","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104773_bib79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41419-023-06211-2","article-title":"Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104773_bib80","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.18632\/oncotarget.1978","article-title":"Targeting Phosphatidylinositide3-Kinase\/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2025.104773_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2022.109152","article-title":"Blocking Adipor1 enhances radiation sensitivity in Hepatoma Carcinoma Cells","volume":"718","author":"Liu","year":"2022","journal-title":"Arch. Biochem Biophys."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib82","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med"},{"issue":"6330","key":"10.1016\/j.critrevonc.2025.104773_bib83","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: Synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib84","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12876-022-02129-9","article-title":"Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy","volume":"22","author":"Luo","year":"2022","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib85","doi-asserted-by":"crossref","first-page":"C299","DOI":"10.1152\/ajpcell.00189.2018","article-title":"MicroRNA-146a-5p enhances radiosensitivity in hepatocellular carcinoma through replication protein A3-induced activation of the DNA repair pathway","volume":"316","author":"Luo","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104773_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/cells13221841","article-title":"Enhancing Proton Therapy Efficacy Through Nanoparticle-Mediated Radiosensitization","volume":"13","author":"Ma","year":"2024","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib87","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1535-7163.MCT-23-0373","article-title":"Roles of cGAS-STING Pathway in Radiotherapy Combined with Immunotherapy for Hepatocellular Carcinoma","volume":"23","author":"Ma","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2025.104773_bib88","article-title":"Radiotherapy with targeted and immunotherapy improved overall survival and progression-free survival for hepatocellular carcinoma with portal vein tumor thrombosis","author":"Ma","year":"2024","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104773_bib89","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib90","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/jhep.2003.50112","article-title":"Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis","volume":"37","author":"Masaki","year":"2003","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104773_bib91","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.tips.2016.06.006","article-title":"Targeting WEE1 Kinase in Cancer","volume":"37","author":"Matheson","year":"2016","journal-title":"Trends Pharm. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib92","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"Matthews","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib93","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104773_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1346407","article-title":"Advances in gross tumor target volume determination in radiotherapy for patients with hepatocellular carcinoma","volume":"14","author":"Meng","year":"2024","journal-title":"Front Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104773_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061668","article-title":"Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies","volume":"12","author":"Mossenta","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2025.104773_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.719896","article-title":"Advances of Targeted Therapy for Hepatocellular Carcinoma","volume":"11","author":"Niu","year":"2021","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib97","article-title":"Organoids to model liver disease","volume":"3","author":"Nuciforo","year":"2021","journal-title":"JHEP Rep."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104773_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105032","article-title":"PC4-mediated Ku complex PARylation facilitates NHEJ-dependent DNA damage repair","volume":"299","author":"Pan","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104773_bib99","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.47995","article-title":"Locoregional Therapies for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis","volume":"7","author":"Patel","year":"2024","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.91","article-title":"Egr-1 regulates irradiation-induced autophagy through Atg4B to promote radioresistance in hepatocellular carcinoma cells","volume":"6","author":"Peng","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.critrevonc.2025.104773_bib101","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8301888","article-title":"m(6)A-Related Angiogenic Genes to Construct Prognostic Signature, Reveal Immune and Oxidative Stress Landscape, and Screen Drugs in Hepatocellular Carcinoma","volume":"2022","author":"Qu","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104773_bib102","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1158\/0008-5472.CAN-08-0763","article-title":"Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation","volume":"68","author":"Rainey","year":"2008","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib103","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/JS9.0000000000000914","article-title":"Benefit of perioperative radiotherapy for hepatocellular carcinoma: a quality-based systematic review and meta-analysis","volume":"110","author":"Rim","year":"2024","journal-title":"Int J. Surg."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib104","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1078-0432.CCR-23-1129","article-title":"A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer","volume":"30","author":"Romesser","year":"2024","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104773_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.957373","article-title":"Role of autophagy in tumor response to radiation: Implications for improving radiotherapy","volume":"12","author":"Roy","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.104773_bib106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","article-title":"Global, regional and national burden of primary liver cancer by subtype","volume":"161","author":"Rumgay","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib107","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijrobp.2023.09.024","article-title":"A Phase 1 Study of the DNA-PK Inhibitor Peposertib in Combination With Radiation Therapy With or Without Cisplatin in Patients With Advanced Head and Neck Tumors","volume":"118","author":"Samuels","year":"2024","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib108","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104773_bib109","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1535-6108(04)00118-7","article-title":"Intratumoral hypoxia, radiation resistance, and HIF-1","volume":"5","author":"Semenza","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib110","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1186\/s12951-024-03011-4","article-title":"Synergistic enhancement of low-dose radiation therapy via cuproptosis and metabolic reprogramming for radiosensitization in in situ hepatocellular carcinoma","volume":"22","author":"Shao","year":"2024","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib111","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1186\/s12885-019-6312-y","article-title":"Aurora-a confers radioresistance in human hepatocellular carcinoma by activating NF-\u03baB signaling pathway","volume":"19","author":"Shen","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib112","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000340","article-title":"ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma","volume":"8","author":"Sheng","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib113","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ijrobp.2024.09.024","article-title":"Antiangiogenic Treatment Facilitates the Abscopal Effect of Radiation Therapy Combined With Anti-PD-1 in Hepatocellular Carcinoma","volume":"121","author":"Sheng","year":"2025","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib114","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1148\/radiol.211986","article-title":"MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy","volume":"303","author":"Shin","year":"2022","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104773_bib115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052637","article-title":"Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments","volume":"22","author":"Shin","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib116","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11912-020-0889-9","article-title":"Proton Beam Therapy in Liver Malignancies","volume":"22","author":"Siddiqui","year":"2020","journal-title":"Curr. Oncol. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib117","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10555-022-10071-1","article-title":"Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities","volume":"42","author":"Sin","year":"2023","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib118","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/neuonc\/noab188","article-title":"Phase I\/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report","volume":"24","author":"Su","year":"2022","journal-title":"Neuro Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib119","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ddr.21914","article-title":"Verbascoside enhances radiosensitivity of hepatocellular carcinoma cells through regulating miR-101-3p\/Wee1 axis","volume":"83","author":"Sun","year":"2022","journal-title":"Drug Dev. Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib120","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1186\/s12885-021-08428-w","article-title":"Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib121","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","article-title":"The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects","volume":"5","author":"Tang","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104773_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2023.100120","article-title":"HDAC3 Controls Liver Homeostasis More by Facilitating Deoxyribonucleic Acid Damage Repair than by Regulating Transcription in Hepatocytes","volume":"103","author":"Tao","year":"2023","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib123","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13046-021-02000-x","article-title":"Interfering with Tumor Hypoxia for Radiotherapy Optimization","volume":"40","author":"Telarovic","year":"2021","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104773_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1400744","article-title":"Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis","volume":"15","author":"Tian","year":"2024","journal-title":"Front Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104773_bib125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/jgh.12931","article-title":"Sonic Hedgehog inhibition as a strategy to augment radiosensitivity of hepatocellular carcinoma","volume":"30","author":"Tsai","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib126","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/hep.29328","article-title":"Targeting histone deacetylase 4\/ubiquitin-conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice","volume":"67","author":"Tsai","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104773_bib127","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s12032-021-01503-z","article-title":"The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors","volume":"38","author":"Une","year":"2021","journal-title":"Med Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib128","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ccell.2023.02.009","article-title":"Functional states of myeloid cells in cancer","volume":"41","author":"van Vlerken-Ysla","year":"2023","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104773_bib129","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s00432-021-03626-2","article-title":"Selinexor decreases HIF-1\u03b1 via inhibition of CRM1 in human osteosarcoma and hepatoma cells associated with an increased radiosensitivity","volume":"147","author":"von Fallois","year":"2021","journal-title":"J. Cancer Res Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000356648","article-title":"Saikosaponin-D enhances radiosensitivity of hepatoma cells under hypoxic conditions by inhibiting hypoxia-inducible factor-1\u03b1","volume":"33","author":"Wang","year":"2014","journal-title":"Cell Physiol. Biochem"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104773_bib131","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1440-1746.2011.06758.x","article-title":"Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1\u03b1 in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients","volume":"26","author":"Wang","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib132","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/cas.14751","article-title":"MiR-320b\/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling","volume":"112","author":"Wang","year":"2021","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib133","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000527696","article-title":"Application of Circular RNA Circ_0071662 in the Diagnosis and Prognosis of Hepatocellular Carcinoma and Its Response to Radiotherapy","volume":"41","author":"Wang","year":"2023","journal-title":"Dig. Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib134","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","article-title":"Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers","volume":"42","author":"Wang","year":"2023","journal-title":"Cancer Metastas-.-. Rev."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib135","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10637-022-01216-8","article-title":"Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors","volume":"40","author":"Waqar","year":"2022","journal-title":"Invest N. Drugs"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib136","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2022.09.060","article-title":"Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src\/STAT3\/NF-\u03baB-Mediated Epithelial-Mesenchymal Transition and Metastasis","volume":"115","author":"Weng","year":"2023","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104773_bib137","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1477459","article-title":"Combination of radiation and interleukin 12 eradicates large orthotopic hepatocellular carcinoma through immunomodulation of tumor microenvironment","volume":"7","author":"Wu","year":"2018","journal-title":"Oncoimmunology"},{"issue":"7446","key":"10.1016\/j.critrevonc.2025.104773_bib138","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","article-title":"Macrophage biology in development, homeostasis and disease","volume":"496","author":"Wynn","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2025.104773_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121793","article-title":"Self-targeting platinum(IV) amphiphilic prodrug nano-assembly as radiosensitizer for synergistic and safe chemoradiotherapy of hepatocellular carcinoma","volume":"289","author":"Xiao","year":"2022","journal-title":"Biomaterials"},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104773_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/cells12162044","article-title":"Coming of Age: Targeting Cyclin K in Cancers","volume":"12","author":"Xiao","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2025.104773_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharm. Ther."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104773_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258817","article-title":"PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K\/AKT\/mTOR pathways and DNA damage repair","volume":"16","author":"Xie","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104773_bib143","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1166\/jbn.2021.3194","article-title":"Lupeol-Loaded Nanoparticles Enhance the Radiosensitivity of Hepatocellular Carcinoma by Inhibiting the Hyperactivation in Raf\/Mitogen-Activated Protein Kinase and Phospatidylinositol-3 Kinase\/mTOR Pathways","volume":"17","author":"Xie","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib144","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/jcp.26005","article-title":"E2F is involved in radioresistance of carbon ion induced apoptosis via Bax\/caspase 3 signal pathway in human hepatoma cell","volume":"233","author":"Xie","year":"2018","journal-title":"J. Cell Physiol."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104773_bib145","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/onc.2010.596","article-title":"hSSB1 binds and protects p21 from ubiquitin-mediated degradation and positively correlates with p21 in human hepatocellular carcinomas","volume":"30","author":"Xu","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104773_bib146","doi-asserted-by":"crossref","first-page":"4713518","DOI":"10.1155\/2022\/4713518","article-title":"ROS-Related miRNAs Regulate Immune Response and Chemoradiotherapy Sensitivity in Hepatocellular Carcinoma by Comprehensive Analysis and Experiment","author":"Xu","year":"2022","journal-title":"Oxid. Med Cell Longev. 2022"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104773_bib147","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.7150\/ijbs.55689","article-title":"URI1 suppresses irradiation-induced reactive oxygen species (ROS) by activating autophagy in hepatocellular carcinoma cells","volume":"17","author":"Xu","year":"2021","journal-title":"Int J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib148","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12967-023-04060-3","article-title":"Tumor cell density dependent IL-8 secretion induces the fluctuation of tregs\/CD8\u2009+\u2009T cells infiltration in hepatocellular carcinoma: one prompt for the existence of density checkpoint","volume":"21","author":"Yan","year":"2023","journal-title":"J. Transl. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib149","article-title":"Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma","volume":"99","author":"Yan","year":"2020","journal-title":"Med. (Baltim. )"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104773_bib150","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1159\/000445551","article-title":"NU7441 Enhances the Radiosensitivity of Liver Cancer Cells","volume":"38","author":"Yang","year":"2016","journal-title":"Cell Physiol. Biochem"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib151","doi-asserted-by":"crossref","first-page":"266","DOI":"10.21147\/j.issn.1000-9604.2023.03.06","article-title":"Advancements in understanding mechanisms of hepatocellular carcinoma radiosensitivity: A comprehensive review","volume":"35","author":"Yang","year":"2023","journal-title":"Chin. J. Cancer Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib152","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.21873\/invivo.13542","article-title":"Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model","volume":"38","author":"Yang","year":"2024","journal-title":"Vivo"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib153","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13014-020-01742-w","article-title":"Axitinib in combination with radiotherapy for advanced hepatocellular carcinoma: a phase I clinical trial","volume":"16","author":"Yang","year":"2021","journal-title":"Radiat. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104773_bib154","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jhep.2022.01.009","article-title":"COMMD10 inhibits HIF1\u03b1\/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma","volume":"76","author":"Yang","year":"2022","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104773_bib155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225170","article-title":"Prognostic value of des-\u03b3-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis","volume":"14","author":"Yang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2025.104773_bib156","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cellsig.2019.04.011","article-title":"Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721 cell proliferation, vasculogenic mimicry, and radioresistance","volume":"60","author":"Yang","year":"2019","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib157","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1186\/s12967-023-04386-y","article-title":"Advances in radiotherapy and immunity in hepatocellular carcinoma","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.critrevonc.2025.104773_bib158","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4566949","article-title":"Chlorogenic Acid, the Main Antioxidant in Coffee, Reduces Radiation-Induced Apoptosis and DNA Damage via NF-E2-Related Factor 2 (Nrf2) Activation in Hepatocellular Carcinoma","volume":"2022","author":"Yin","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib159","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/CM9.0000000000002988","article-title":"AZD1775 and anti-PD-1 antibody synergistically sensitize hepatoma to radiotherapy","volume":"137","author":"Yin","year":"2024","journal-title":"Chin. Med J. (Engl. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib160","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3350\/cmh.2020.0095","article-title":"Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model study","volume":"27","author":"Yoo","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104773_bib161","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.tem.2024.06.003","article-title":"Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment","volume":"35","author":"Yu","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104773_bib162","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1002\/cam4.2570","article-title":"Clinical significance of radiotherapy before and\/or during nivolumab treatment in hepatocellular carcinoma","volume":"8","author":"Yu","year":"2019","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib163","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2012.10.024","article-title":"Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo","volume":"329","author":"Yu","year":"2013","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104773_bib164","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijrobp.2020.12.062","article-title":"CLTRN, Regulated by NRF1\/RAN\/DLD Protein Complex, Enhances Radiation Sensitivity of Hepatocellular Carcinoma Cells Through Ferroptosis Pathway","volume":"110","author":"Yuan","year":"2021","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2025.104773_bib165","doi-asserted-by":"crossref","DOI":"10.1177\/15330338231206335","article-title":"Proton Beam Therapy and Photon-Based Magnetic Resonance Image-Guided Radiation Therapy: The Next Frontiers of Radiation Therapy for Hepatocellular Carcinoma","volume":"22","author":"Zaki","year":"2023","journal-title":"Technol. Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib166","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12916-022-02554-3","article-title":"NUPR1 contributes to radiation resistance by maintaining ROS homeostasis via AhR\/CYP signal axis in hepatocellular carcinoma","volume":"20","author":"Zhan","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.critrevonc.2025.104773_bib167","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2021.01.089","article-title":"TTK inhibitor promotes radiosensitivity of liver cancer cells through p21","volume":"550","author":"Zhang","year":"2021","journal-title":"Biochem Biophys. Res Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104773_bib168","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.ijrobp.2022.11.022","article-title":"Deficiency of Carbamoyl Phosphate Synthetase 1 Engenders Radioresistance in Hepatocellular Carcinoma via Deubiquitinating c-Myc","volume":"115","author":"Zhang","year":"2023","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2025.104773_bib169","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1508028","article-title":"Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2025.104773_bib170","article-title":"Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance of Head and Neck Cancer: From Basic Research to Clinical Application","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2025.104773_bib171","article-title":"Lactate: The Mediator of Metabolism and Immunosuppression","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104773_bib172","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1210\/me.2011-0081","article-title":"Orphan receptor TR3 enhances p53 transactivation and represses DNA double-strand break repair in hepatoma cells under ionizing radiation","volume":"25","author":"Zhao","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.104773_bib173","first-page":"1","article-title":"Stereotactic Body Radiotherapy Combined with Transcatheter Arterial Chemoembolization versus Stereotactic Body Radiotherapy Alone as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review","volume":"64","author":"Zhao","year":"2020","journal-title":"Chemotherapy"},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104773_bib174","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.7150\/ijbs.64003","article-title":"CDC20 regulates the cell proliferation and radiosensitivity of P53 mutant HCC cells through the Bcl-2\/Bax pathway","volume":"17","author":"Zhao","year":"2021","journal-title":"Int J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104773_bib175","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.90911","article-title":"Nifuroxazide suppresses PD-L1 expression and enhances the efficacy of radiotherapy in hepatocellular carcinoma","volume":"12","author":"Zhao","year":"2024","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib176","first-page":"48","article-title":"The miR-34a-5p-c-MYC-CHK1\/CHK2 Axis Counteracts Cancer Stem Cell-Like Properties and Enhances Radiosensitivity in Hepatocellular Cancer Through Repression of the DNA Damage Response","volume":"199","author":"Zhao","year":"2023","journal-title":"Radiat. Res"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib177","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1159\/000491774","article-title":"The Role of Canonical Wnt Signaling in Regulating Radioresistance","volume":"48","author":"Zhao","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib178","doi-asserted-by":"crossref","first-page":"669","DOI":"10.7150\/jca.61622","article-title":"PERK Regulates the Sensitivity of Hepatocellular Carcinoma Cells to High-LET Carbon Ions via either Apoptosis or Ferroptosis","volume":"13","author":"Zheng","year":"2022","journal-title":"J. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104773_bib179","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41419-023-06009-2","article-title":"Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2","volume":"14","author":"Zheng","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2025.104773_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.686621","article-title":"Safety of PD-1\/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma","volume":"11","author":"Zhong","year":"2021","journal-title":"Front Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104773_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12100943","article-title":"Novel Implications of Nanoparticle-Enhanced Radiotherapy and Brachytherapy: Z-Effect and Tumor Hypoxia","volume":"12","author":"Zhou","year":"2022","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104773_bib182","doi-asserted-by":"crossref","first-page":"5516","DOI":"10.1080\/21655979.2021.1965694","article-title":"Overexpression of ADAM9 decreases radiosensitivity of hepatocellular carcinoma cell by activating autophagy","volume":"12","author":"Zhu","year":"2021","journal-title":"Bioengineered"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib183","doi-asserted-by":"crossref","DOI":"10.3390\/biom12040580","article-title":"Effects of Glucose Metabolism, Lipid Metabolism, and Glutamine Metabolism on Tumor Microenvironment and Clinical Implications","volume":"12","author":"Zhu","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104773_bib184","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/HEP.0000000000000776","article-title":"Sintilimab plus bevacizumab combined with radiotherapy as first-line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A multicenter, single-arm, phase 2 study","volume":"80","author":"Zhu","year":"2024","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104773_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100678","article-title":"Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578\/IGF1R axis in hepatocellular carcinoma","volume":"27","author":"Zhu","year":"2022","journal-title":"Ann. Hepatol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104773_bib186","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071878","article-title":"Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib","volume":"12","author":"Znati","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:28:40Z","timestamp":1762352920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":186,"alternative-id":["S1040842825001611"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104773","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiosensitization strategies for hepatocellular carcinoma: Mechanisms, therapeutic advances, and clinical perspectives","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104773"}}